202 related articles for article (PubMed ID: 32416725)
41. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
[TBL] [Abstract][Full Text] [Related]
42. Role of ventral hippocampal GABA(A) and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test.
Rezvanfard M; Zarrindast MR; Bina P
Pharmacology; 2009; 84(6):356-66. PubMed ID: 19907194
[TBL] [Abstract][Full Text] [Related]
43. Linalool-rich essential oils from the Amazon display antidepressant-type effect in rodents.
Dos Santos ÉRQ; Maia CSF; Fontes Junior EA; Melo AS; Pinheiro BG; Maia JGS
J Ethnopharmacol; 2018 Feb; 212():43-49. PubMed ID: 29037915
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Zaitone SA; El-Wakeil AF; Abou-El-Ela SH
Behav Pharmacol; 2012 Aug; 23(4):417-25. PubMed ID: 22750843
[TBL] [Abstract][Full Text] [Related]
45. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
46. The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes.
Pereira MM; de Morais H; Dos Santos Silva E; Corso CR; Adami ER; Carlos RM; Acco A; Zanoveli JM
Metab Brain Dis; 2018 Oct; 33(5):1573-1584. PubMed ID: 29934859
[TBL] [Abstract][Full Text] [Related]
47. The aqueous crude extract of Montanoa frutescens produces anxiolytic-like effects similarly to diazepam in Wistar rats: involvement of GABAA receptor.
Carro-Juárez M; Rodríguez-Landa JF; Rodríguez-Peña Mde L; Rovirosa-Hernández Mde J; García-Orduña F
J Ethnopharmacol; 2012 Sep; 143(2):592-8. PubMed ID: 22885072
[TBL] [Abstract][Full Text] [Related]
48. Agastache mexicana may produce anxiogenic-like actions in the male rat.
Molina-Hernández M; Téllez-Alcántara P; Martínez E
Phytomedicine; 2000 Jun; 7(3):199-203. PubMed ID: 11185730
[TBL] [Abstract][Full Text] [Related]
49. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
50. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
[TBL] [Abstract][Full Text] [Related]
51. Anxiolytic-like activity of zinc in rodent tests.
Partyka A; Jastrzębska-Więsek M; Szewczyk B; Stachowicz K; Sławińska A; Poleszak E; Doboszewska U; Pilc A; Nowak G
Pharmacol Rep; 2011; 63(4):1050-5. PubMed ID: 22001993
[TBL] [Abstract][Full Text] [Related]
52. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
53. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
[TBL] [Abstract][Full Text] [Related]
54. The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines.
Saitoh A; Sugiyama A; Yamada M; Inagaki M; Oka J; Nagase H; Yamada M
Neuropharmacology; 2013 Apr; 67():485-93. PubMed ID: 23246531
[TBL] [Abstract][Full Text] [Related]
55. Anxiolytic- and anxiogenic-like effects of Montanoa tomentosa (Asteraceae): Dependence on the endocrine condition.
Estrada-Camarena E; Sollozo-Dupont I; Islas-Preciado D; González-Trujano ME; Carro-Juárez M; López-Rubalcava C
J Ethnopharmacol; 2019 Sep; 241():112006. PubMed ID: 31153863
[TBL] [Abstract][Full Text] [Related]
56. Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABA(A) receptors.
Hajizadeh Moghaddam A; Hosseini RS; Roohbakhsh A
Pharmacol Rep; 2012; 64(1):45-53. PubMed ID: 22580519
[TBL] [Abstract][Full Text] [Related]
57. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
Wierońska JM; Papp M; Pilc A
Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
[TBL] [Abstract][Full Text] [Related]
58. Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
Mak P; Broussard C; Vacy K; Broadbear JH
J Psychopharmacol; 2012 Apr; 26(4):532-42. PubMed ID: 21890582
[TBL] [Abstract][Full Text] [Related]
59. Antidepressant and anxiolytic-like activity of sodium selenite after acute treatment in mice.
Kędzierska E; Dudka J; Poleszak E; Kotlińska JH
Pharmacol Rep; 2017 Apr; 69(2):276-280. PubMed ID: 28167456
[TBL] [Abstract][Full Text] [Related]
60. Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety.
Gupta D; Radhakrishnan M; Kurhe Y
Eur J Pharmacol; 2014 Nov; 742():94-101. PubMed ID: 25199966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
